The role of GLP-1 medications in weight loss is an interesting side effect observed in some people using these drugs for diabetes management
Your goal is to create a sustainable calorie deficit that feels manageable, not punishing
Furthermore, concentrations of up to 300 mM glucose do not induce GLP-1 secretion from colonic human mucosa because GLP-1 producing L-cells barely express SGLT1 ( Consistently, the use of -methyl-D-glucopyranoside (MDG), an acaloric substrate of SGLT1, within 5 min triggers the release of GLP-1 as glucose does, demonstrating how it is the sodium current that triggers the release of the incretin, and not the metabolic ATP-driven arrest of potassium currents and following calcium spike ( The pharmacological blockage of SGLT-1 with phloridzin, in a rat small intestine perfused system, results in just a halved secretion of GIP, GLP-1, or PYY, and the addition of phloretin, a GLUT2 inhibitor, brings these values down to basal levels
Injecting into the same small spot repeatedly can cause lipohypertrophy, which is a small lump of fat and scar tissue under the skin
Each vial is manufactured under GMP-aligned protocols with 99% purity verification, comprehensive third-party testing, and complete chain-of-custody documentation
Some individuals may experience a noticeable energy boost and mental clarity within days, while others may need a few weeks of consistent daily use to feel the full effects